| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,377 |
2,796 |
$380K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,632 |
4,120 |
$293K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,510 |
1,134 |
$287K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
595 |
460 |
$97K |
| 80053 |
Comprehensive metabolic panel |
3,309 |
2,955 |
$94K |
| 36415 |
Collection of venous blood by venipuncture |
6,903 |
5,599 |
$70K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,238 |
3,737 |
$58K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
430 |
350 |
$33K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
721 |
235 |
$31K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
633 |
384 |
$22K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
439 |
363 |
$22K |
| 84484 |
|
435 |
355 |
$21K |
| 86140 |
|
808 |
709 |
$16K |
| 83605 |
|
295 |
241 |
$14K |
| 80305 |
|
1,559 |
1,369 |
$13K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
77 |
73 |
$9K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
33 |
32 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
469 |
287 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
330 |
232 |
$8K |
| 81001 |
|
774 |
691 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
134 |
102 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
246 |
220 |
$7K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
128 |
105 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
195 |
170 |
$6K |
| 80306 |
|
127 |
114 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
52 |
50 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
50 |
39 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
111 |
80 |
$3K |
| 82077 |
|
99 |
92 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
222 |
203 |
$3K |
| 83690 |
|
182 |
159 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
126 |
123 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
94 |
75 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
471 |
400 |
$2K |
| 80061 |
Lipid panel |
66 |
61 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
103 |
95 |
$2K |
| 87081 |
|
176 |
159 |
$2K |
| 82150 |
|
148 |
133 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
81 |
78 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
201 |
172 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
19 |
17 |
$1K |
| 84703 |
|
56 |
48 |
$1K |
| 83880 |
|
16 |
14 |
$829.12 |
| 83874 |
|
14 |
12 |
$829.12 |
| 74019 |
|
14 |
12 |
$646.94 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
28 |
25 |
$589.25 |
| 87486 |
|
19 |
17 |
$572.88 |
| 87581 |
|
19 |
17 |
$572.88 |
| 81003 |
|
42 |
39 |
$274.62 |
| 82550 |
|
33 |
27 |
$261.53 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
16 |
16 |
$258.40 |
| 82553 |
|
15 |
13 |
$252.94 |
| J2704 |
Injection, propofol, 10 mg |
27 |
25 |
$230.55 |
| 87807 |
|
25 |
22 |
$226.36 |
| 83735 |
|
14 |
12 |
$212.18 |
| 82728 |
|
12 |
12 |
$210.74 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
26 |
24 |
$180.92 |
| 85610 |
|
14 |
12 |
$146.98 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31 |
26 |
$70.58 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14 |
12 |
$53.51 |
| A9270 |
Non-covered item or service |
17 |
12 |
$0.00 |